Need Help with Your CEFALY? Learn how to get the most out of your treatment in a free one-on-one coaching session. Schedule Now!

×

CEFALY provides effective acute migraine treatment at home

The Trial of eTNS for the Acute treatment of Migraine (TEAM) study found that the use of self-administered 2-hour eTNS therapy with CEFALY is a safe and effective therapeutic option, with or without the use of acute anti-migraine medications.

The TEAM study is the largest sham-controlled clinical trial examining the use of any e-TNS therapy for the treatment of migraine headache.

26 percent

of CEFALY users reported pain freedom after 2 hours of treatment

57 percent

of CEFALY users reported resolution of their most bothersome migraine symptom

43 percent

of CEFALY users reported resolution of all migraine symptoms

Read the TEAM study

CEFALY significantly reduces migraine pain

In the Acute Migraine Therapy with External Trigeminal Neurostimulation (ACME) study, patients saw a reduction in migraine pain intensity following a 60-minute ACUTE treatment session with CEFALY. This was a double-blind, randomized, sham-controlled study conducted across multiple headache centers in the U.S.

59 percent

reduction in migraine pain intensity, on average, following one hour of treatment with CEFALY. This relief continued up to 24 hours

79 percent

of acute migraine sufferers saw pain relief

32 percent

of acute migraine sufferers saw pain freedom

Read the ACME study

CEFALY significantly decreases the number of migraine days

With compliant daily use of CEFALY s 20-minute PREVENT treatment, patients experienced a significant reduction in the number of migraine days, the Migraine Prevention with a Supraorbital Transcutaneous Stimulator (PREMICE) study found.

Adverse events were mild and fully reversible within 20 minutes, without intervention. This was a double-blind, randomized, sham-controlled study conducted across multiple Belgian tertiary headache centers.

38 percent

38.1% of CEFALY users saw at least a 50% reduction in the number of migraine days.

30 percent

30% (mean 2.06) reduction in migraine days in verum group.

Read the PREMICE study

Who should use CEFALY?

CEFALY is indicated to be used for:

  • Acute treatment of migraine with or without aura in patients 18 years of age or older

  • Preventative treatment of episodic migraine with or without aura in patients 18 years of age or older.


CEFALY is ideal for people with migraine who:

  • Don t respond to pharmaceutical treatments or seek clinically proven effective alternatives to pharmaceuticals.

  • Have prior medical conditions and are unable to take traditional pharmaceuticals.

  • Have limited access to outpatient treatment procedures.

What are the side effects of using CEFALY?

CEFALY has few side effects, which have been demonstrated to be minor and fully reversible with cessation of device use.
If you experience any serious side effects, or if any side effects persist for more than a few weeks, stop use of your CEFALY device and consult your healthcare provider or seek immediate medical attention.

Common

  • Sleepiness
  • Headache After a Session

Uncommon

  • Forehead Skin Redness
  • Nausea

Rare

  • Forehead Skin Allergy

Get the CEFALY Connected

Gain new insight into your migraine treatment journey. The Bluetooth-enabled CEFALY Connected allows you to optimize your treatments by tracking them on your phone.